Digital Therapeutics (DTx) have immense potential to transform healthcare—empowering patients, reducing healthcare costs, unburdening healthcare professionals, and redefining clinical trial data collection and analysis.
However, because they are an emerging medical treatment, they face unique challenges every step of the journey from genesis to post-market monitoring.
In this guide, Castor discusses routes to commercialization and tools to meet the challenges on the path to market.
What you will learn:
- Pros and cons of traditional vs. novel commercialization routes
- Case studies for three different routes including FDA emergency authorization
- Choosing the right commercialization route for you